Close
0
Inquiry Basket

There is no product in the shopping cart, buy it!

Hot Products
Monosaccharide Products
Oligosaccharide Products
Polysaccharide Products
Carbohydrate-based Surfactant Products
Blood Group Antigen Products
Glycoprotein Products
Glycopeptide Products
Nucleotide Sugar Products
Glycoprotein Assay Kits
Comprehensive Glycoprotein Reagents
Glycoengineered Cell Products
Glycoengineering Viral Particle Products
Glycolipid Products

GlycoFlux™ Human SIGLEC2 Overexpression Raji Cell Line

CAT#: GLJF-0925-JF1033

Datasheet Request COA
Overview Specification Target Information Related Products
Overview
Description
GlycoFlux™ human SIGLEC2 overexpression Raji cell line is a stable cell line engineered to overexpress SIGLEC2 (CD22), a B-cell lectin that binds sialic acid and regulates BCR signaling, endocytosis, and activation. It localizes to endosomes and is implicated in diffuse large B-cell lymphoma. This model supports research on B-cell biology, immune regulation, and lymphoma.
Product Type
Overexpression Cell Lines
Species
Human
Cell Morphology
Lymphoblast-like, suspension growth
Passage Ratio
1:2~1:4
Cell Line
Raji
Primary Disease
Burkitt's lymphoma
Lineage
B lymphocyte (B cell)
Lineage Subtype
Mature B cell, widely used in EBV-related studies
Specification
Cell Viability
>90%
Sterility Test
The sterility test indicated an absence of microbial growth.
Identity Test
STR identification
Mycoplasma Test
Negative
Virus Test
Negative for HIV, HBV and HCV.
Genetic Stability Testing
We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation
qPCR, Sanger Sequencing
Culture Medium
FBS & RPMI
Application
Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.
Size
1 M cells/vial*2
Product Format
Frozen
Shipping
Dry ice
Availability Status
Made to order
Handling Notes
Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer
This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Target Information
Target
SIGLEC2
Full Name
Sialic Acid Binding Ig Like Lectin 2
Alternative Name
SIGLEC-2; CD22; Sialic Acid Binding Ig Like Lectin
Location
19q13.12
Gene ID
8778
Summary
Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome. Implicated in diffuse large B-cell lymphoma.
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.